Barclays Downgrades Novo Nordisk (NVO) to Underweight
Tweet
Share
E-mailGet Alerts NVO Hot Sheet
Price: $45.23 -0.22%
Rating Summary:
8 Buy, 17 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Rating Summary:
8 Buy, 17 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Join SI Premium – FREE
Barclays downgraded Novo Nordisk (NYSE: NVO) from Equalweight to Underweight.
For an analyst ratings summary and ratings history on Novo Nordisk click here. For more ratings news on Novo Nordisk click here.
Shares of Novo Nordisk closed at $151.88 yesterday.
For an analyst ratings summary and ratings history on Novo Nordisk click here. For more ratings news on Novo Nordisk click here.
Shares of Novo Nordisk closed at $151.88 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler Double Downgrades Myriad Genetics (MYGN) to Underweight, 'Major Strategic Action Likely Needed'
- UBS Downgrades Shanghai Chicmax Cosmetic (2145:HK) to Neutral
- BofA Securities Downgrades PG&E Corporation (PCG) to Neutral, 'A comprehensive reform opportunity falls short'
Create E-mail Alert Related Categories
DowngradesRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
